Antithrombins
Cardiopulmonary Bypass
Myocardial Infarction
Off-Label Use
Percutaneous Coronary Intervention

Bivalirudin

Bivalirudin, a direct thrombin inhibitor, plays a crucial role in the management and treatment of patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction. This comprehensive activity delves into the nuanced aspects of bivalirudin therapy, shedding light on its indications, action, and contraindications. Beyond bivalirudin’s established role in PCI, this session explores the broader applications of bivalirudin in thromboembolic disease, cardiopulmonary bypass, and extracorporeal membrane oxygenation. Participants will gain an in-depth understanding of the drug’s mechanism of action, adverse event profile, off-label uses, dosing, monitoring parameters, contraindications, and potential drug interactions, empowering them to navigate the complexities of managing patients undergoing PCI and other related conditions. This educational initiative equips healthcare professionals with the competency to manage diverse aspects of bivalirudin therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.